Science Explorer Back to mapMap

Most cited papers from Moravek Biochemicals (United States)

Moravek Biochemicals (United States)

What are the most cited papers from Moravek Biochemicals (United States)?

The most cited paper from Moravek Biochemicals (United States) is "Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro" (Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al., 2004), with 221 citations. Next come "Cellular pharmacology and biological activity of 5-carboranyl-2′-deoxyuridine" (48) and "Nucleobase transporter-mediated permeation of 2‘,3‘-dideoxyguanosine in human erythrocytes and human T-lymphoblastoid CCRF-CEM cells." (28).

Showing 13 of 13 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al. · Journal of Virology Open access 27 Jul 2004 221
2 Cellular pharmacology and biological activity of 5-carboranyl-2′-deoxyuridine Raymond F. Schinazi, Naganna M. Goudgaon, Géraldine Fulcrand et al. · International Journal of Radiation Oncology*Biology*Physics Mar 1994 48
3 Nucleobase transporter-mediated permeation of 2‘,3‘-dideoxyguanosine in human erythrocytes and human T-lymphoblastoid CCRF-CEM cells. W P Gati, A.R. Paterson, D. Lorne Tyrrell et al. · Journal of Biological Chemistry Open access Nov 1992 28
4 Cellular Pharmacology of the D - and L -Enantiomers of β-5-o-Carboranyl-2′-deoxyuridine Selwyn J. Hurwitz, Li Ma, Alessandra Eleuteri et al. · Nucleosides Nucleotides & Nucleic Acids Mar 2000 16
5 Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy‐13C‐3,3‐2H2)‐labeled and (3‐14C)‐labeled 7‐(2‐carboxyethyl)‐1,3‐dihydro‐1‐hydroxy‐2,1‐benzoxaboroles Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom et al. · Journal of Labelled Compounds and Radiopharmaceuticals 26 Apr 2012 16
6 Synthesis of labeled ambroxol and its major metabolites Bachir Latli, Matt J. Hrapchak, Heinz‐Karl Switek et al. · Journal of Labelled Compounds and Radiopharmaceuticals 9 Nov 2009 12
7 Synthesis of tritium‐labeled (R,R)‐4‐methoxyfenoterol Joseph A. Kozocas, James E. Bupp, Mary J. Tanga et al. · Journal of Labelled Compounds and Radiopharmaceuticals Open access 3 Dec 2009 7
8 Synthesis of 5,5-dimethyl-1-pyrroline-N-oxide-2-14C Diem Duy Le, Yinsheng Zhang, Danh V. Nguyen et al. · Journal of Labelled Compounds and Radiopharmaceuticals 2000 4
9 Synthesis of 14C-radiolabeled oligonucleotides with a novel phosphoramidite reagent Andrei P. Guzaev, Brunel Boyode, Guity Balow et al. · Bioorganic & Medicinal Chemistry Letters May 1998 4
10 A novel synthesis of isoeugenol, [ring‐(U)‐14C] J.E. Immoos · Journal of Labelled Compounds and Radiopharmaceuticals 26 Aug 2015 3
11 Carboxylation reaction of a highly functionalized vinylic anion: a case of unexpected stability and reactivity Laurent Gomez, Jiejun Wu, Neelakandha S. Mani et al. · Tetrahedron Letters 29 Dec 2009 1
12 Syntheses of N-t-butyl-?-phenylnitrone-?-14C and ?-(4-pyridyl-1-oxide)-N-t-butylnitrone-?-14C Diem Duy Le, Yinsheng Zhang, David H. T. Chien et al. · Journal of Labelled Compounds and Radiopharmaceuticals 2000 1
13 Use of [4,6-Di-14C]-5′-DMT-thymidine Phosphoramidite Reagent for the Radiolabeling of Synthetic Oligonucleotides Andrei P. Guzaev, Brunel Boyode, Guity Balow et al. · Nucleosides and Nucleotides Jun 1999 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.